The Canadian Study of Arterial Inflammation in Patients with Diabetes and Recent Vascular Events, Evaluation of Colchicine Effectiveness (CADENCE): protocol for a randomised, double-blind, placebo-controlled trial.

MLA

Boczar, Kevin Emery, et al. “The Canadian Study of Arterial Inflammation in Patients with Diabetes and Recent Vascular Events, Evaluation of Colchicine Effectiveness (CADENCE): Protocol for a Randomised, Double-Blind, Placebo-Controlled Trial.” BMJ Open, vol. 13, no. 11, Nov. 2023, p. e074463. EBSCOhost, https://doi.org/10.1136/bmjopen-2023-074463.

APA

Boczar, K. E., Shin, S., deKemp, R. A., Dowlatshahi, D., Tavoosi, A., Wiefels, C., Liu, P., Lochnan, H., MacPherson, P. A., Chong, A. Y., Torres, C., Leung, E., Tawakol, A., Ahmadi, A., Garrard, L., Lefebvre, C., Kelly, C., MacPhee, P., Tilokee, E., … Beanlands, R. (2023). The Canadian Study of Arterial Inflammation in Patients with Diabetes and Recent Vascular Events, Evaluation of Colchicine Effectiveness (CADENCE): protocol for a randomised, double-blind, placebo-controlled trial. BMJ Open, 13(11), e074463. https://doi.org/10.1136/bmjopen-2023-074463

Chicago

Boczar, Kevin Emery, Sheojung Shin, Robert A deKemp, Dar Dowlatshahi, Anahita Tavoosi, Christiane Wiefels, Peter Liu, et al. 2023. “The Canadian Study of Arterial Inflammation in Patients with Diabetes and Recent Vascular Events, Evaluation of Colchicine Effectiveness (CADENCE): Protocol for a Randomised, Double-Blind, Placebo-Controlled Trial.” BMJ Open 13 (11): e074463. doi:10.1136/bmjopen-2023-074463.